Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
095700 | KO
Overview
Corporate Details
- ISIN(s):
- KR7095700001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
- Website:
- http://www.genexine.com/
- Sector:
- Manufacturing
Description
Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-20 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 89.7 KB | ||
| 2025-01-07 00:00 |
기타시장안내 (연구개발 우수기업 매출액 특례적용 관련)
|
Korean | 2.7 KB | ||
| 2024-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.2 MB | ||
| 2024-11-14 00:00 |
투자판단관련주요경영사항 (에페사프리필드시린지주(GXE4) 한국 품목허가 신청 자진취하)
|
Korean | 7.9 KB | ||
| 2024-11-14 00:00 |
투자판단관련주요경영사항 (에페사프리필드시린지주(GXE4) 한국 품목허가 재신청)
|
Korean | 12.1 KB | ||
| 2024-10-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.1 KB | ||
| 2024-10-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.0 KB | ||
| 2024-10-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.0 KB | ||
| 2024-10-11 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 508.5 KB | ||
| 2024-10-02 00:00 |
합병등종료보고서(합병)
|
Korean | 28.9 KB | ||
| 2024-08-29 00:00 |
기타경영사항(자율공시) (소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고 )
|
Korean | 12.3 KB | ||
| 2024-08-29 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.1 KB | ||
| 2024-08-16 00:00 |
[기재정정]반기보고서 (2024.06)
|
Korean | 1.2 MB | ||
| 2024-08-13 00:00 |
반기보고서 (2024.06)
|
Korean | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genexine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genexine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
